Impact of OMT on the Symptoms of Dysmenorrhea
Assessing the Impact of Osteopathic Manipulative Treatment on Dysmenorrhea
1 other identifier
interventional
30
1 country
1
Brief Summary
This pilot study will span two months per participant and include a baseline evaluation, a control period, the treatment itself, and an after-treatment evaluation. After getting informed consent, participants will be asked to fill out surveys about their menstrual cycles and health histories, including pain levels, timing, and the types and length of symptoms they may have. Participants will then go through a month control period where they will have their cycle without any osteopathic manipulative treatment (OMT) being given, followed by a standard osteopathic exam. They will be asked to fill out all surveys again at this time. They will then go through OMT 3-7 days before their next period. After their second cycle, they will complete a final survey. Participants' pain and symptoms will be assessed at each time point by comparing survey responses and checking for improvement. The goal of this study is to see whether osteopathic manipulative treatment reduces pain and eases symptoms, and whether this approach is practical for future studies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 30, 2026
CompletedFirst Submitted
Initial submission to the registry
September 10, 2026
CompletedFirst Posted
Study publicly available on registry
September 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
September 30, 2026
September 1, 2026
1.7 years
September 10, 2026
September 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Menstrual Pain Numeric Scale Rating (NRS)
The NRS is a widely used and validated tool for measuring menstrual pain in subjects participating in clinical trials. This self-reported pain scale ranges from 0 to 10. A score of zero indicates no pain, and a score of 10 indicates the worst possible pain.
Baseline, at the end of Cycle 1 (each cycle is 28 days), and at the end of Cycle 2 (an additional 28 days).
Secondary Outcomes (3)
Premenstrual Syndrome Scale (PMSS) Scores
Baseline, at the end of Cycle 1 (each cycle is 28 days), and at the end of Cycle 2 (an additional 28 days).
Working Ability, Location, Intensity, Days of Pain, Dysmenorrhea (WaLIDD) Score
Baseline, at the end of Cycle 1 (each cycle is 28 days), and at the end of Cycle 2 (an additional 28 days).
Modified Quantitative Analgesic Questionnaire (QAQ)
Baseline, at the end of Cycle 1 (each cycle is 28 days), and at the end of Cycle 2 (an additional 28 days).
Study Arms (1)
Control time period vs. OMT Intervention period
EXPERIMENTALThis single-arm study consists of participants undergoing a 1-month control period with no intervention prior to their menstrual cycle, during which they don't alter their daily lives. This is followed by a second month in which they undergo a menstrual cycle with OMT intervention 3-7 days before menstruation.
Interventions
Manual applied therapeutic techniques to correct somatic dysfunction and asymmetry of the lumbar and cervical pelvis and sacrum. This includes soft-tissue, articulatory, muscle energy, myofascial release, and High-Velocity Low-Amplitude (HVLA).
Eligibility Criteria
You may qualify if:
- Female Western University of Health Sciences students, faculty, or staff who experience dysmenorrhea symptoms.
You may not qualify if:
- Individuals who are pregnant or breastfeeding.
- Individuals under the age of 20 and over the age of 51.
- Individuals with a history of endometriosis or PCOS.
- Individuals with a history of thyroid conditions.
- Individuals who change or plan ot change birth control during the course of the study.
- Individuals receiving outside OMT or physical therapy treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Western University of Health Sciences
Pomona, California, 91766-1854, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Redding, DO
Western University of Health Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of NMM/OMM and Family Medicine
Study Record Dates
First Submitted
September 10, 2026
First Posted
September 30, 2026
Study Start
April 30, 2026
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
September 30, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- After the study is published.
- Access Criteria
- All interested research professionals.
All components of this study will be made available to other researchers if desired. Please reach out to the PI with requests.